Malaysia approves Pfizer–BioNTech booster for adults over 18
Malaysia has conditionally approved the Pfizer–BioNTech COVID-19 vaccine as a booster for individuals over 18 who completed their primary series at least six months prior. The approval includes eligibility for senior citizens, immunocompromised individuals, and healthcare workers.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthMalaysia approves Pfizer–BioNTech booster for adults over 18
Sign in or subscribeBrowse free archive reportsMalaysia has conditionally approved the Pfizer–BioNTech COVID-19 vaccine as a booster for individuals over 18 who completed their primary series at least six months prior. The approval includes eligibility for senior citizens, immunocompromised individuals, and healthcare workers.